Concepedia

Shu‐Wei Yang

SY

Statistics

Publications

47

Citations

1.2K

H-Index

21

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Illinois Chicago

Cubist Pharmaceuticals (United States)

LabCorp (United States)

Shu‐Wei Yang is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and biochemistry.

ORCID

Top concepts

Publications per year

1995–2023

47

Publications

47

New Steroid Acids from Antrodia cinnamomea, a Fungal Parasite of Cinnamomum micranthum

Chung-Hsiung Chen, Shu‐Wei Yang, Ya‐Ching Shen · Journal of Natural Products · 1995 · 138 citations

TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci

Sang Ho Lee, Hao Wang, Marc Labroli et al. · Science Translational Medicine · 2016 · 108 citations

Chemokine Receptor CCR-5 Inhibitors Produced by<i>Chaetomium</i><i>g</i><i>lobosum</i>

Shu‐Wei Yang, Ronald Mierzwa, Joseph Terracciano et al. · Journal of Natural Products · 2006 · 57 citations · Full text

, , +15

Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia

Shu‐Wei Yang, Jennifer Smotryski, William T. McElroy et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 52 citations · Full text

, , +7

Metabolism Studies of Indole Derivatives Using a Staurosporine Producer,<i>Streptomyces staurosporeus</i>

Shu‐Wei Yang, Geoffrey A. Cordell · Journal of Natural Products · 1997 · 48 citations

1–5 of 47